PortfoliosLab logoPortfoliosLab logo
IVZ vs. CME
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IVZ vs. CME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Ltd. (IVZ) and CME Group Inc. (CME). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IVZ achieves a 15.75% return, which is significantly higher than CME's -3.78% return. Over the past 10 years, IVZ has underperformed CME with an annualized return of 5.37%, while CME has yielded a comparatively higher 13.98% annualized return.


IVZ

1D
0.44%
1M
15.25%
6M
7.07%
YTD
15.75%
1Y
44.56%
3Y*
28.09%
5Y*
8.68%
10Y*
5.37%
ALL TIME*
8.14%

CME

1D
0.39%
1M
10.20%
6M
-7.06%
YTD
-3.78%
1Y
-4.31%
3Y*
14.94%
5Y*
8.25%
10Y*
13.98%
ALL TIME*
19.60%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$676.33M$811.49M$857.23M
$140.57M$131.54M$143.36M

IVZ vs. CME - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IVZ
Invesco Ltd.
15.75%56.94%3.02%6.05%-18.71%35.56%3.06%14.91%-52.05%24.67%
CME
CME Group Inc.
-3.78%19.83%15.41%31.32%-22.89%29.47%-6.34%9.67%32.15%32.35%

Correlation

The correlation between IVZ and CME is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.08

Correlation (3Y)
Calculated over the trailing 3-year period

-0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Dec 6, 2002

0.35

The correlation between IVZ and CME shifts across timeframes, from -0.08 (1 year) to 0.35 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

IVZ:

$13.27B

CME:

$92.51B

EPS

IVZ:

-$0.62

CME:

$11.82

PS Ratio

IVZ:

2.13

CME:

13.63

Total Revenue (TTM)

IVZ:

$6.38B

CME:

$6.77B

Gross Profit (TTM)

IVZ:

$2.75B

CME:

$5.55B

EBITDA (TTM)

IVZ:

$1.38B

CME:

$5.37B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IVZ vs. CME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IVZ
IVZ Risk / Return Rank: 8080
Overall Rank
IVZ Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
IVZ Sortino Ratio Rank: 7979
Sortino Ratio Rank
IVZ Omega Ratio Rank: 7878
Omega Ratio Rank
IVZ Calmar Ratio Rank: 8080
Calmar Ratio Rank
IVZ Martin Ratio Rank: 8181
Martin Ratio Rank

CME
CME Risk / Return Rank: 3838
Overall Rank
CME Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
CME Sortino Ratio Rank: 3333
Sortino Ratio Rank
CME Omega Ratio Rank: 3333
Omega Ratio Rank
CME Calmar Ratio Rank: 4343
Calmar Ratio Rank
CME Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IVZ vs. CME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Ltd. (IVZ) and CME Group Inc. (CME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IVZCMEDifference
Sharpe ratioReturn per unit of total volatility

+1.54

Sortino ratioReturn per unit of downside risk

+1.97

Omega ratioGain probability vs. loss probability

1.24

0.99

+0.25

Calmar ratioReturn relative to maximum drawdown

2.03

-0.14

+2.17

Martin ratioReturn relative to average drawdown

5.35

-0.41

+5.76

IVZ vs. CME - Sharpe Ratio Comparison

The current IVZ Sharpe Ratio is 1.36, which is higher than the CME Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of IVZ and CME, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IVZ vs. CME - Drawdown Comparison

The maximum IVZ drawdown since its inception was -83.91%, which is greater than CME's maximum drawdown of -77.50%. Use the drawdown chart below to compare losses from any high point for IVZ and CME.


Loading charts...

Drawdown Indicators


IVZCMEDifference

Max Drawdown

Largest peak-to-trough decline

-83.91%

-77.50%

-6.41%

Max Drawdown (1Y)

Largest decline over 1 year

-22.03%

-31.09%

+9.06%

Max Drawdown (3Y)

Largest decline over 3 years

-36.52%

-31.09%

-5.43%

Max Drawdown (5Y)

Largest decline over 5 years

-48.88%

-31.74%

-17.14%

Max Drawdown (10Y)

Largest decline over 10 years

-79.72%

-37.36%

-42.36%

Current Drawdown

Current decline from peak

-1.87%

-19.51%

+17.64%

Average Drawdown

Average peak-to-trough decline

-35.86%

-20.70%

-15.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.36%

10.45%

-2.09%

Volatility

IVZ vs. CME - Volatility Comparison

Invesco Ltd. (IVZ) and CME Group Inc. (CME) have volatilities of 9.76% and 9.66%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IVZCMEDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.76%

9.66%

+0.10%

Volatility (6M)

Calculated over the trailing 6-month period

26.19%

19.78%

+6.41%

Volatility (1Y)

Calculated over the trailing 1-year period

32.92%

23.46%

+9.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.66%

20.64%

+16.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

39.16%

24.13%

+15.03%

Dividends

IVZ vs. CME - Dividend Comparison

IVZ's dividend yield for the trailing twelve months is around 2.82%, less than CME's 4.41% yield.


PositionTTM20252024202320222021202020192018201720162015
CME
CME Group Inc.
4.41%1.83%4.48%4.58%5.05%3.00%3.24%2.74%2.42%4.20%4.90%5.41%
IVZ
Invesco Ltd.
2.82%3.18%4.66%6.15%4.07%2.89%4.45%6.84%7.11%3.15%3.66%3.17%

Financials

IVZ vs. CME - Financials Comparison

This section allows you to compare key financial metrics between Invesco Ltd. and CME Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.20B1.40B1.60B1.80B20222023202420252026
1.69B
1.71B
(IVZ) Total Revenue
(CME) Total Revenue
Values in USD except per share items

IVZ vs. CME - Profitability Comparison

The chart below illustrates the profitability comparison between Invesco Ltd. and CME Group Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
67.0%
69.3%
Portfolio components
IVZ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Invesco Ltd. reported a gross profit of 1.13B and revenue of 1.69B. Therefore, the gross margin over that period was 67.0%.

CME - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, CME Group Inc. reported a gross profit of 1.18B and revenue of 1.71B. Therefore, the gross margin over that period was 69.3%.

IVZ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Invesco Ltd. reported an operating income of -1.46B and revenue of 1.69B, resulting in an operating margin of -86.2%.

CME - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, CME Group Inc. reported an operating income of 1.11B and revenue of 1.71B, resulting in an operating margin of 64.9%.

IVZ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Invesco Ltd. reported a net income of -1.06B and revenue of 1.69B, resulting in a net margin of -62.7%.

CME - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, CME Group Inc. reported a net income of 1.04B and revenue of 1.71B, resulting in a net margin of 61.1%.


Frequently Asked Questions


IVZ and CME have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IVZ has higher volatility (9.76%) compared to CME (9.66%). In terms of maximum drawdown, IVZ dropped -83.91% vs CME's -77.50%.

IVZ currently has the higher Sharpe Ratio (1.36 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IVZ and CME

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer